These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27705192)

  • 21. [Is an intensive glycaemic control beneficial in diabetes type 2?].
    Martin S
    Dtsch Med Wochenschr; 2011 Sep; 136(39):1940. PubMed ID: 21948602
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypoglycaemic therapy in type 2 diabetes. Part I. Metformin is the only glucose-lowering drug known to prevent complications of diabetes.
    Prescrire Int; 2015 Apr; 24(159):103-6. PubMed ID: 25941708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pleiotropic effects of metformin: time for prospective studies.
    Bromage DI; Yellon DM
    Cardiovasc Diabetol; 2015 Aug; 14():109. PubMed ID: 26271457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
    Laakso M
    Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination treatment with ipragliflozin and metformin: a randomized, double-blind, placebo-controlled study in patients with type 2 diabetes mellitus.
    Veltkamp SA; van Dijk J; Collins C; van Bruijnsvoort M; Kadokura T; Smulders RA
    Clin Ther; 2012 Aug; 34(8):1761-71. PubMed ID: 22795925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decrease mortality in type II diabetes mellitus: glycemic and renal function control.
    Borghi C; Ventura F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138
    [No Abstract]   [Full Text] [Related]  

  • 27. Review: metformin: potential benefits and use in chronic kidney disease.
    Pilmore HL
    Nephrology (Carlton); 2010 Jun; 15(4):412-8. PubMed ID: 20609092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comment from the diabetology viewpoint].
    Stahl M
    Praxis (Bern 1994); 2008 Aug; 97(17):943-4. PubMed ID: 18777777
    [No Abstract]   [Full Text] [Related]  

  • 29. Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment.
    Gore MO; McGuire DK
    Diab Vasc Dis Res; 2012 Apr; 9(2):85-8. PubMed ID: 22496441
    [No Abstract]   [Full Text] [Related]  

  • 30. The shifting paradigm in the treatment of type 2 diabetes mellitus-A cardiologist's perspective.
    Fatima S; Jameel A; Ayesha F; Menzies DJ
    Clin Cardiol; 2017 Nov; 40(11):970-973. PubMed ID: 28841228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Basal insulin has a "neutral effect" on cardiovascular events].
    Overbeck P
    MMW Fortschr Med; 2012 Jun; 154(12):24. PubMed ID: 22880290
    [No Abstract]   [Full Text] [Related]  

  • 32. [Metformin and lactic acidosis--fact or fiction? A review of current data].
    Bläuer SC; Keller U
    Praxis (Bern 1994); 2003 Nov; 92(47):2008-10. PubMed ID: 14669502
    [No Abstract]   [Full Text] [Related]  

  • 33. Repurposing Metformin for Cardiovascular Disease.
    Rena G; Lang CC
    Circulation; 2018 Jan; 137(5):422-424. PubMed ID: 29378754
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular trials and diabetes treatments: a regulatory maze.
    Matthews DR
    Diab Vasc Dis Res; 2012 Apr; 9(2):83-4. PubMed ID: 22419242
    [No Abstract]   [Full Text] [Related]  

  • 35. Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes.
    Mannucci E; Monami M; Ceriello A; Rotella CM
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):375-377. PubMed ID: 28242233
    [No Abstract]   [Full Text] [Related]  

  • 36. Metformin therapy and clinical uses.
    Scarpello JH; Howlett HC
    Diab Vasc Dis Res; 2008 Sep; 5(3):157-67. PubMed ID: 18777488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].
    Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
    Ter Arkh; 2010; 82(8):34-41. PubMed ID: 20873243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [++UKPDS Study. Metformin in obese patients with Type 2 diabetes (UKPDS 340].
    Janka HU
    Internist (Berl); 2000 Jul; 41(7):688-9. PubMed ID: 10929259
    [No Abstract]   [Full Text] [Related]  

  • 39. New insights into the anti-diabetic actions of metformin: from the liver to the gut.
    Wu T; Horowitz M; Rayner CK
    Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):157-166. PubMed ID: 27983877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.
    Lamanna C; Monami M; Marchionni N; Mannucci E
    Diabetes Obes Metab; 2011 Mar; 13(3):221-8. PubMed ID: 21205121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.